FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1761837778> ?p ?o ?g. }

• W1761837778 endingPage "e0136991" @default.
• W1761837778 startingPage "e0136991" @default.
• W1761837778 abstract "Mesenchymal stem cells (MSCs) have been broadly used experimentally in various clinical contexts. The addition of MSCs to initial steroid therapy for acute graft-versus-host disease (aGVHD) may improve patient outcomes. However, investigations regarding prognostic factors affecting the efficacy of MSC therapy for steroid-refractory aGVHD remain controversial. We thus conducted a systematic review and meta-analysis of published clinical trials to determine possible prognostic factors affecting the efficacy of MSCs in treating steroid-refractory aGVHD.Clinical trials using MSC therapy for steroid-refractory aGVHD were identified by searching PubMed and EMBASE databases. A total of 6,963 citations were reviewed, and 13 studies met the inclusion criteria. A total of 301 patients from thirteen studies were included. Of these, 136 patients showed a complete response (CR), and 69 patients displayed a partial (PR) or mixed response (MR). In total, 205 patients exhibited overall response (ORR). Patients with skin steroid-refractory aGVHD showed a better clinical response than gastrointestinal (CR: odds ratio [OR] = 1.93, 95% confidence interval [95%CI]: 1.05-3.57, p < 0.05) and liver (CR: OR = 2.30, 95%CI: 1.12-4.69, p < 0.05, and ORR: OR = 2.93, 95%CI: 1.06-8.08, p < 0.05) steroid-refractory aGVHD. Those with grade II steroid-refractory aGVHD exhibited a better clinical response following MSC therapy than recipients with grade III-IV (CR: OR = 3.22, 95%CI: 1.24-8.34, p < 0.05). Completion therapy may improve the CR but reduce ORR compared with induction therapy (CR: OR = 0.20, 95%CI: 0.09-0.44, p < 0.05; ORR: OR = 2.18, 95%CI: 1.17-4.05, p = 0.01). There was also a trend towards a better clinical response in children compared with adults (CR: OR = 2.41, 95%CI: 1.01-5.73, p = 0.05).Age, skin involvement, lower aGVHD grade, and the number of infusions are the main prognostic factors affecting the efficacy of MSC therapy for steroid-refractory aGVHD." @default.
• W1761837778 created "2016-06-24" @default.
• W1761837778 creator A5017833334 @default.
• W1761837778 creator A5019762150 @default.
• W1761837778 creator A5023148075 @default.
• W1761837778 creator A5064683226 @default.
• W1761837778 creator A5083507260 @default.
• W1761837778 creator A5086537561 @default.
• W1761837778 date "2015-08-31" @default.
• W1761837778 modified "2023-10-13" @default.
• W1761837778 title "Efficacy of Mesenchymal Stem Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease following Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis" @default.
• W1761837778 cites W1268509098 @default.
• W1761837778 cites W149992400 @default.
• W1761837778 cites W1509523292 @default.
• W1761837778 cites W1970974588 @default.
• W1761837778 cites W1972954994 @default.
• W1761837778 cites W1978468353 @default.
• W1761837778 cites W1985977074 @default.
• W1761837778 cites W1986142040 @default.
• W1761837778 cites W1986974915 @default.
• W1761837778 cites W1988489929 @default.
• W1761837778 cites W1990082923 @default.
• W1761837778 cites W1992265745 @default.
• W1761837778 cites W1995850152 @default.
• W1761837778 cites W1999670686 @default.
• W1761837778 cites W2000487018 @default.
• W1761837778 cites W2002305938 @default.
• W1761837778 cites W2006491993 @default.
• W1761837778 cites W2007536176 @default.
• W1761837778 cites W2009045750 @default.
• W1761837778 cites W2012302358 @default.
• W1761837778 cites W2013107151 @default.
• W1761837778 cites W2020828534 @default.
• W1761837778 cites W2028239901 @default.
• W1761837778 cites W2033230449 @default.
• W1761837778 cites W2033284503 @default.
• W1761837778 cites W2037015581 @default.
• W1761837778 cites W2041864288 @default.
• W1761837778 cites W2049783422 @default.
• W1761837778 cites W2050668010 @default.
• W1761837778 cites W2055857323 @default.
• W1761837778 cites W2066297886 @default.
• W1761837778 cites W2066609974 @default.
• W1761837778 cites W2069251929 @default.
• W1761837778 cites W2070090685 @default.
• W1761837778 cites W2076568423 @default.
• W1761837778 cites W2081940406 @default.
• W1761837778 cites W2083434602 @default.
• W1761837778 cites W2087583213 @default.
• W1761837778 cites W2089878334 @default.
• W1761837778 cites W2095666785 @default.
• W1761837778 cites W2108881298 @default.
• W1761837778 cites W2112095092 @default.
• W1761837778 cites W2114998726 @default.
• W1761837778 cites W2122125669 @default.
• W1761837778 cites W2123368042 @default.
• W1761837778 cites W2133908459 @default.
• W1761837778 cites W2138946470 @default.
• W1761837778 cites W2142911739 @default.
• W1761837778 cites W2145512995 @default.
• W1761837778 cites W2170433336 @default.
• W1761837778 cites W4251857914 @default.
• W1761837778 cites W2039365064 @default.
• W1761837778 doi "https://doi.org/10.1371/journal.pone.0136991" @default.
• W1761837778 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4554731" @default.
• W1761837778 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26323092" @default.
• W1761837778 hasPublicationYear "2015" @default.
• W1761837778 type Work @default.
• W1761837778 sameAs 1761837778 @default.
• W1761837778 citedByCount "58" @default.
• W1761837778 countsByYear W17618377782016 @default.
• W1761837778 countsByYear W17618377782017 @default.
• W1761837778 countsByYear W17618377782018 @default.
• W1761837778 countsByYear W17618377782019 @default.
• W1761837778 countsByYear W17618377782020 @default.
• W1761837778 countsByYear W17618377782021 @default.
• W1761837778 countsByYear W17618377782022 @default.
• W1761837778 countsByYear W17618377782023 @default.
• W1761837778 crossrefType "journal-article" @default.
• W1761837778 hasAuthorship W1761837778A5017833334 @default.
• W1761837778 hasAuthorship W1761837778A5019762150 @default.
• W1761837778 hasAuthorship W1761837778A5023148075 @default.
• W1761837778 hasAuthorship W1761837778A5064683226 @default.
• W1761837778 hasAuthorship W1761837778A5083507260 @default.
• W1761837778 hasAuthorship W1761837778A5086537561 @default.
• W1761837778 hasBestOaLocation W17618377781 @default.
• W1761837778 hasConcept C126322002 @default.
• W1761837778 hasConcept C142424586 @default.
• W1761837778 hasConcept C142724271 @default.
• W1761837778 hasConcept C143998085 @default.
• W1761837778 hasConcept C156957248 @default.
• W1761837778 hasConcept C198826908 @default.
• W1761837778 hasConcept C2777408962 @default.
• W1761837778 hasConcept C2779972918 @default.
• W1761837778 hasConcept C2911091166 @default.
• W1761837778 hasConcept C44249647 @default.
• W1761837778 hasConcept C535046627 @default.
• W1761837778 hasConcept C71924100 @default.

• next